Some Winners Emerge Despite China’s Reimbursement Price-Cutting Scheme

Higher Volumes Benefit Selected PD-1s

 
• By Dexter Jie Yan
  
winners from China NRDL scheme
BeiGene and Innovent appear to take lead in revenue growth • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia